Checkpoint Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Warrants (Details) - Warrants - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Warrants, Outstanding beginning balance	4,357,597	1,249
Warrants, Granted	35,513,575	4,356,361
Warrants, Exercised	(9,773,501)
Warrants, Fractional share adjustment		(13)
Warrants, Outstanding ending balance	30,097,671	4,357,597
Warrants, Weighted Average Exercise Price, beginning balance	$ 3.37	$ 0
Weighted Average Exercise Price, Granted	2.30	3.37
Warrants, Weighted Average Exercise Price, Exercised	1.76
Warrants, Weighted Average Exercise Price, ending balance	$ 2.36	$ 3.37
Warrants, Remaining contractual life	3 years	3 years 3 months 3 days	3 years 9 months 29 days